https://www.selleckchem.com/TGF-beta.html
A paradigm shift is needed in the current approach to synthesizing harms. Differences in harms results across reviews can occur because the choice of harms is driven by reviewer preferences, rather than standardized approaches to selecting harms for assessment. A paradigm shift is needed in the current approach to synthesizing harms. We compared methods used with current recommendations for synthesizing harms in systematic reviews and meta-analyses (SRMAs) of gabapentin. We followed recommended systematic review practices. We selected reliable